Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron

[1]  J. Molnar,et al.  Role of Anemia in Home Oxygen Therapy in Chronic Obstructive Pulmonary Disease Patients , 2015, American journal of therapeutics.

[2]  R. Luján,et al.  Prevalencia de anemia asociada a la enfermedad pulmonar obstructiva crónica. Estudio de las variables asociadas , 2013 .

[3]  P. Alonso González,et al.  Prevalence of anaemia associated with chronic obstructive pulmonary disease. Study of associated variables. , 2013, Archivos de bronconeumologia.

[4]  R. Jörres,et al.  Hemoglobin Levels Above Anemia Thresholds Are Maximally Predictive for Long-Term Survival in COPD With Chronic Respiratory Failure , 2013, Respiratory Care.

[5]  C. Martínez-Rivera,et al.  Anaemia in chronic obstructive pulmonary disease. Does it really matter? , 2013, International journal of clinical practice.

[6]  N. Vaziri.  Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  Wim Van Biesen,et al.  Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  Akshay S. Desai,et al.  Treatment of anemia with darbepoetin alfa in systolic heart failure. , 2013, The New England journal of medicine.

[9]  P. Ponikowski,et al.  Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF) , 2013, European journal of heart failure.

[10]  P. Ponikowski,et al.  Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives , 2012, European heart journal.

[11]  S. Berliner,et al.  Association of angiotensin-converting enzyme inhibitor therapy initiation with a reduction in hemoglobin levels in patients without renal failure. , 2012, Mayo Clinic proceedings.

[12]  Herbert Y. Lin,et al.  Mechanisms of anemia in CKD. , 2012, Journal of the American Society of Nephrology : JASN.

[13]  M. Polkey,et al.  Anemia and Survival in Chronic Obstructive Pulmonary Disease: A Dichotomous rather than a Continuous Predictor , 2012, Respiration.

[14]  I. Stanopoulos,et al.  Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study. , 2012, QJM : monthly journal of the Association of Physicians.

[15]  Shanping Jiang,et al.  Update in diagnosis and therapy of coexistent chronic obstructive pulmonary disease and chronic heart failure. , 2012, Journal of thoracic disease.

[16]  Courtney Crim,et al.  Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype , 2012, PloS one.

[17]  J. Morera,et al.  Anemia is a Mortality Predictor in Hospitalized Patients for COPD Exacerbation , 2012, COPD.

[18]  W. Willett,et al.  Iron Status Predicts Treatment Failure and Mortality in Tuberculosis Patients: A Prospective Cohort Study from Dar es Salaam, Tanzania , 2012, PloS one.

[19]  Jack David,et al.  Does It Really Matter , 2012 .

[20]  K. Dickstein,et al.  Aliskiren, ALTITUDE, and the implications for ATMOSPHERE , 2012, European journal of heart failure.

[21]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[22]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[23]  N. Vaziri,et al.  Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD , 2012, International Urology and Nephrology.

[24]  Y. Obase,et al.  Nutritional deficits in elderly smokers with respiratory symptoms that do not fulfill the criteria for COPD , 2011, International journal of chronic obstructive pulmonary disease.

[25]  J. Wharton,et al.  Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. , 2011, Journal of the American College of Cardiology.

[26]  I. Stanopoulos,et al.  Anemia of Chronic Disease in Chronic Obstructive Pulmonary Disease: A Case-Control Study of Cardiopulmonary Exercise Responses , 2011, Respiration.

[27]  J. Wharton,et al.  Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target , 2011, European Respiratory Journal.

[28]  R. Jörres,et al.  Anaemia in chronic respiratory failure , 2011, International journal of clinical practice.

[29]  K. Kostikas,et al.  Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. , 2011, European journal of internal medicine.

[30]  D. Silverberg.  The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome , 2011, Heart Failure Reviews.

[31]  N. Westerhof,et al.  Iron deficiency is common in idiopathic pulmonary arterial hypertension , 2010, European Respiratory Journal.

[32]  K. Filion,et al.  Correcting anemia in heart failure: the efficacy and safety of erythropoiesis-stimulating agents. , 2010, Journal of cardiac failure.

[33]  D. Goldsmith.  2009: a requiem for rHuEPOs--but should we nail down the coffin in 2010? , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[34]  E. Unger,et al.  Erythropoiesis-stimulating agents--time for a reevaluation. , 2010, The New England journal of medicine.

[35]  J. Walters,et al.  Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. , 2010, The Cochrane database of systematic reviews.

[36]  M. Flather,et al.  Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients (Intervention Review) , 2010 .

[37]  Ajay K. Singh.  Does TREAT give the boot to ESAs in the treatment of CKD anemia? , 2010, Journal of the American Society of Nephrology : JASN.

[38]  P. Ponikowski,et al.  Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.

[39]  Alvar Agusti,et al.  Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.

[40]  Thomas G. Smith,et al.  Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. , 2009, JAMA.

[41]  W. Hörl,et al.  Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome. , 2009, The oncologist.

[42]  C. Datz,et al.  Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. , 2009, Blood.

[43]  P. J. Barnes,et al.  Systemic manifestations and comorbidities of COPD , 2009, European Respiratory Journal.

[44]  D. V. van Veldhuisen,et al.  Erythropoietin treatment in patients with chronic heart failure: a meta-analysis , 2009, Heart.

[45]  N. Vaziri,et al.  Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  P. Burney,et al.  A multivariate analysis of serum nutrient levels and lung function , 2008, Respiratory research.

[47]  E. Nemeth.  Iron regulation and erythropoiesis , 2008, Current opinion in hematology.

[48]  J. Doyle,et al.  Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications , 2008, Current medical research and opinion.

[49]  R. Huber,et al.  Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis , 2007, Pediatric pulmonology.

[50]  P. Casañ,et al.  Alta frecuencia de anemia en pacientes con EPOC ingresados en un hospital de tercer nivel , 2007 .

[51]  S. Mody,et al.  Haemoglobin level and its clinical impact in a cohort of patients with COPD , 2007, European Respiratory Journal.

[52]  J. Belda,et al.  [High frequency of anemia in COPD patients admitted in a tertiary hospital]. , 2007, Revista clinica espanola.

[53]  Merlin C. Thomas,et al.  Anemia in diabetes: marker or mediator of microvascular disease? , 2007, Nature Clinical Practice Nephrology.

[54]  P. Calverley,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[55]  J. Schmier,et al.  Anemia, costs and mortality in Chronic Obstructive Pulmonary Disease , 2006, Cost effectiveness and resource allocation : C/E.

[56]  H. Schünemann,et al.  Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease , 2006, BMC pulmonary medicine.

[57]  S. Anker,et al.  Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. , 2006, International journal of cardiology.

[58]  Robert Wise,et al.  Predictors of mortality in patients with emphysema and severe airflow obstruction. , 2006, American journal of respiratory and critical care medicine.

[59]  T. Similowski,et al.  The potential impact of anaemia of chronic disease in COPD , 2006, European Respiratory Journal.

[60]  W. Ershler,et al.  Economic burden of patients with anemia in selected diseases. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[61]  Thomas Similowski,et al.  Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. , 2005, Chest.

[62]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[63]  Stefan D Anker,et al.  Anemia and inflammation in COPD. , 2005, Chest.

[64]  E. Wouters,et al.  A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. , 2003, Chest.

[65]  I. Shapira,et al.  The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. , 2001, Journal of the American College of Cardiology.

[66]  I. Shapira,et al.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.

[67]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[68]  D. Köhler,et al.  Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. , 1998, Critical care medicine.

[69]  H. Böhrer,et al.  Blood transfusion facilitating difficult weaning from the ventilator , 1998, Anaesthesia.

[70]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.